Between the late 1940s and early 1950s, humans manufactured polyfluoroalkyl compounds (PFCs) using electrochemical fluorination and telomerisation technologies, whereby hydrogen atoms are substituted by fluorine atoms, thus conferring unnatural and unique physicochemical properties to these compounds. Presently, there are wide ranges of PFCs, and owing to their bioaccumulative properties, they have been detected in various environmental matrices and in human sera. It has thus been suggested that they are hazardous. Hence, this review aims at highlighting the recent development in PFC research, with a particular focus on perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS), the most studied and predominantly found PFCs in various environmental matrices, although recent reports have included perfluorobutane sulfonate (PFBS), which was previously regarded as innocuously harmless, when compared to its counterparts, PFOA and PFOS. As such, proper investigations are thus required for a better understanding of short-chain PFC substitutes, which have been suggested as suitable replacements to long-chained PFCs, although these substitutes have also been suggested to pose various health risks comparable to those associated with long-chain PFCs. Similarly, several novel technologies, such as PFC reduction using zero-valent iron, including removal at point of use, adsorption and coagulation, have been proposed. However, regardless of how efficient removers some of these techniques have proven to be, short-chain PFCs remain a challenge to overcome for scientists, in this regard.

This study presents the biological treatment of poultry slaughterhouse wastewater (PSW) using a combination of a biological pretreatment stage, an expanded granular sludge bed reactor (EGSB), and a membrane bioreactor (MBR) to treat PSW. This PSW treatment was geared toward reducing the concentration of contaminants present in the PSW to meet the City of Cape Town (CoCT) discharge standards and evaluate an alternative means of treating medium- to high-strength wastewater at low cost. The EGSB used in this study was operated under mesophilic conditions and at an organic loading rate (OLR) of 69 to 456 mg COD/L·h. The pretreatment stage of this laboratory-scale (lab-scale) plant played an important role in the pretreatment of the PSW, with removal percentages varying between 20% and 50% for total suspended solids (TSS), 20% and 70% for chemical oxygen demand (COD), and 50% and 83% for fats, oil, and grease (FOG). The EGSB further reduced the concentration of these contaminants to between 25% and 90% for TSS, 20% and 80% for COD, and 20% and >95% for FOG. The last stage of this process, i.e., the membrane bioreactor (MBR), contributed to a further decrease in the concentration of these contaminants with a peak removal performance of >95% for TSS and COD and 80% for the FOG. Overall, the system (pretreatment–EGSB–MBR) exceeded 97% for TSS and COD removal and 97.5% for FOG removal. These results culminated in a product (treated wastewater) meeting the discharge standards.

Type 2 diabetes mellitus (T2DM) is the most common form of diabetes and it is characterized by high blood sugar and abnormal sera lipid levels. Although the specific reasons for the development of these abnormalities are still not well understood, traditionally, genetic and lifestyle behavior have been reported as the leading causes of this disease. In the last three decades, the number of diabetic patients has drastically increased worldwide, with current statistics suggesting the number is to double in the next two decades. To combat this incurable ailment, orthodox medicines, to which economically disadvantaged patients have minimal access to, have been used. Thus, a considerable amalgamation of medicinal plants has recently been proven to possess therapeutic capabilities to manage T2DM, and this has prompted studies primarily focusing on the healing aspect of these plants, and ultimately, their commercialization. Hence, this review aims to highlight the potential threat of pollutants, i.e., polyfluoroalkyl compounds (PFCs), endocrine disrupting chemicals (EDCs) and heavy metals, to medicinal plants, and their prospective impact on the phytomedicinal therapy strategies for T2DM. It is further suggested that auxiliary research be undertaken to better comprehend the factors that influence the uptake of these compounds by these plants. This should include a comprehensive risk assessment of phytomedicinal products destined for the treatment of T2DM. Regulations that control the use of PFC-precursors in certain developing countries are also long overdue.

Your article is protected by copyright and all rights are held exclusively by Springer-Verlag GmbH Germany, part of Springer Nature. This e-offprint is for personal use only and shall not be self-archived in electronic repositories. If you wish to self-archive your article, please use the accepted manuscript version for posting on your own website. You may further deposit the accepted manuscript version in any repository, provided it is only made publicly available 12 months after official publication or later and provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

No abstract